Skip to content
mda-logo_stacked-all white
  • Subscribe
  • Newsletter
  • Advertise
  • MDA.org
  • Donate
Ques_media_logo

Ques_media_logo
Subscribe
Donate

  • Magazine
    • Current Issue
    • Past Issues
  • Featured Content
  • Topics
    • Advocacy
    • Finding a Diagnosis
    • Get Involved
    • Health
    • Inclusion
    • Independence
    • Lifestyle
    • News
    • Personal Stories
    • Science + Research
  • Diseases A-Z
  • Blog
  • Podcast
  • Product Guide
  • Career Quest

Research

Scientific conference speakers
Featured Article

A Successful In-Person Conference

By MDA Staff | May 13, 2022
Blog Post

Brain-Computer Interface Technology Could Improve Life for Millions

By Larry Luxner | May 9, 2022
Blog Post

Simply Stated: Inclusion Body Myositis, Revisited

By Sujatha Gurunathan | April 27, 2022
Blog Post

Promoting Diversity in Rare Disease Research

By Larry Luxner | April 8, 2022
MG clinical trial
Blog Post

Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults Living with gMG

By MDA Staff | April 6, 2022
dermatomyositis clinical trial
Blog Post

Clinical Trial Alert: Phase 2 Study of Ravulizumab (Ultomiris) in Adults Living with Dermatomyositis

By MDA Staff | April 5, 2022
Blog Post

Simply Stated: What is Myotonic Dystrophy?

By Sujatha Gurunathan | March 24, 2022
Blog Post

2022 Clinical & Scientific Conference March 15 Highlights

By Sujatha Gurunathan | March 15, 2022
Clinical & Scientific Conference
Blog Post

2022 Clinical & Scientific Conference March 14 Highlights

By Sujatha Gurunathan | March 14, 2022
Blog Post

Clinical Trial Alert: Phase 1b/2a Study of WVE-N531 in a Subset of People Living with DMD

By Sujatha Gurunathan | March 11, 2022
  • « Previous
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 27
  • Next »
  • Media
  • Careers
  • Donate
  • Contact Quest
muscular-dystrophy-association
Muscular Dystrophy Association, Inc.
1016 W Jackson Blvd #1073
Chicago, IL 60607
800-572-1717 | ResourceCenter@mdausa.org

 

Manage Your Quest Media Subscriptions










The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. ©2022, Muscular Dystrophy Association Inc. All rights reserved.

Privacy Policy | Terms of Use | State Fundraising Notices

Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset